Acrivon Therapeutics Inc. provided updated phase II data for checkpoint kinase candidate ACR-368, highlighting promising response rates for biomarker-positive patients with endometrial cancer and ...
The University of Pennsylvania has taken a novel approach to ensure that women with suspicious adnexal lesions are referred ...
The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback